Menactra Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg) Injection - 0.5 ml/1 Vial Vaccine (Refrigerator)

Product Overview:

• Menactra Vaccine(Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg)) is used to prevent meningococcal disease. This is indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C,Y and W-135. It is approved for use in individuals 9 months through 55 years of age.


• Menactra Vaccine is given by a healthcare professional and should not be self-administered. It is important to receive all the doses of the vaccine to be effective. A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease, if at least 4 to 6 years have elapsed since the prior dose. Do not administer this product intravenously, subcutaneously, or intradermally.


• Some common side effects of this medicine include injection site reactions (such as pain, swelling, redness), irritability, sleepiness, headache, nausea, vomiting, and diarrhea. If these side effects do not go away with time or get worse, let the doctor know. The doctor may help with ways to reduce or prevent these symptoms.


• To make sure the vaccine is safe, before receiving the vaccine, it is important to let the doctor know if you have any other illnesses. You should also tell the doctor about all the medicines you are taking. Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.

How it works?:

• Menactra Vaccine contains Meningococcal Polysaccharides of serogroups A, C, Y, and W-135 antigens. It also contains diphtheria toxoid protein, that acts as a carrier for the individual serogroup antigens. This vaccine helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.

Benefits:

• Meningococcal disease is a serious bacterial infection of the lining of the brain and spinal cord. It spreads through close contact with an infected person. Although this infection can occur in people of any age group, it is more common in children and teens.


• Menactra Vaccine helps prevent Meningococcal disease. It helps the immune system to produce antibodies to fight against meningococcal infection. It is advisable to consult your doctor for complete information regarding vaccination schedules.

Directions for Use:

• Menactra vaccine is administered as a single 0.5 mL dose via intramuscular injection, preferably in the anterolateral thigh for infants and young children and in the deltoid region for older individuals.


• For children aged 9 to 23 months, a 2-dose series is required, with doses administered at least three months apart. For individuals aged 2 to 55 years: A single dose is sufficient.


• Booster Vaccination (ages 15 to 55 years): A single booster dose may be given if at least 4 years have elapsed since the previous dose and the individual remains at ongoing risk for meningococcal disease.

Active Ingredient(s):

• Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg)

Side Effects:

• Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Cautions & Warnings:

• Ensure appropriate medical treatment is available should an allergic reaction (eg, anaphylactic reaction) occurs


• Syncope reported; place proper protocols to avoid injury from syncope


• Some individuals with altered immunocompetence, including some individuals receiving immunosuppressant therapy, may have reduced immune responses to drug

Pregnancy Warnings:

• Consult your doctor to discuss your specific situation and consider the potential benefits and risks of vaccination with Menactra during pregnancy.

Breastfeeding Warnings:

• Limited information is available about the use of Menactra vaccine during breastfeeding; it is essential to consult your physician before receiving this vaccine while breastfeeding.

Storage:

• Do NOT freeze; discard frozen/previously frozen product


• Unopened: Refrigerate at 36-46ºF (2-8ºC); discard after expiration date


• Discard any unused portion

FAQ:

• Q. Can Menactra vaccine cause side effects?


• A. Yes, like all vaccines, it can have side effects. The most common include redness, pain, or


• swelling at the injection site, and possibly some fussiness, headaches, or tiredness. Serious


• allergic reactions are rare but possible.

• Q. Who should not receive the Menactra vaccine?


• A. Individuals who have experienced a severe allergic reaction to a previous meningococcal,


• diphtheria, or similar vaccine, or to any component of the Menactra vaccine, should not receive


• it. If you have a moderate or severe fever or illness, it is advisable to wait until you are feeling


• better.

• Q. What should I do if I miss a dose?


• A. If you miss a dose, consult your doctor about when you should receive it.


• Q. Can Menactra vaccine interact with other vaccines or medicines?


• A. It can be administered with certain other vaccines, but they should be given in separate


• injections at different sites on the body. Some medications that weaken your immune system


• might reduce the vaccine's effectiveness. Inform your doctor about all the medications you are


• taking.